» Articles » PMID: 25153374

Pulmonary Function in Children with Type 1 Diabetes Mellitus

Overview
Date 2014 Aug 26
PMID 25153374
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: To assess lung function in children and adolescents with type 1 diabetes mellitus (T1DM).

Patients And Methods: We conducted a case-control study of 100 patients with T1DM [median age 13 (10.6-14.7), 44% men, 23% prepubertal, and all nonsmokers] and 77 controls. None had evidence of lung disease or any other comorbidity. We performed pulmonary function tests, including spirometry [forced vital capacity (FVC), forced expiratory volume in 1 s (FEV₁), and FEV₁/FVC ratio], plethysmography [total lung capacity (TLC), residual volume (RV), RV/TLC ratio, and airway resistance (Raw)], and diffusing capacity of carbon monoxide in the lung (TLCO), alveolar volume (AV), and TLCO/AV ratio. The duration of diabetes, degree of metabolic control, insulin dose, and presence of diabetic complications were registered. The χ²-test and analysis of variance were used to compare categorical and quantitative variables, respectively.

Results: The duration of diabetes was 6.2±3.8 years with a median HbA₁c of 7.08±0.4%. FEV₁/FVC ratio was found to be significantly higher in patients with TIDM than in controls. Patients with diabetes also had a nonsignificant trend towards lower FVC, FEV₁, Raw, and TLCO, and higher RV, TLC, and RV/TLC than controls. There were no differences in pulmonary function based on duration of disease or metabolic control. We found differences in pulmonary evaluation when pubertal stage was analyzed.

Conclusions: The lung is functionally involved in children with T1DM. Pubertal development stage influences the evaluation of lung function.

Citing Articles

The Jiangtang Tongmai Prescription Inhibits Inflammation and Fibrosis of Lung Fibroblast Autophagy Induced by Hyperglycemia by Regulating CAV1 Expression.

Ding N, Fan Y, Zheng C Endocr Metab Immune Disord Drug Targets. 2023; 24(6):717-724.

PMID: 37622706 DOI: 10.2174/1871530323666230824165645.


Change in pulmonary function tests and their relation to the serum levels of ceruloplasmin, copper and superoxide dismutase in patients suffering from Type-1 and Type-2 diabetes.

Lathiya N, Aziz Q, Fawwad A, Siddiqui I, Basit A Pak J Med Sci. 2023; 39(3):880-884.

PMID: 37250546 PMC: 10214808. DOI: 10.12669/pjms.39.3.6485.


How Comorbidities Affect Hospitalization from Influenza in the Pediatric Population.

Mylonakis S, Mylona E, Kalligeros M, Shehadeh F, Chan P, Mylonakis E Int J Environ Res Public Health. 2022; 19(5).

PMID: 35270503 PMC: 8910429. DOI: 10.3390/ijerph19052811.


The Diabetic Lung: Insights into Pulmonary Changes in Children and Adolescents with Type 1 Diabetes.

Mameli C, Ghezzi M, Mari A, Cammi G, Macedoni M, Redaelli F Metabolites. 2021; 11(2).

PMID: 33530418 PMC: 7912250. DOI: 10.3390/metabo11020069.


Effect of Subcutaneous Insulin on Spirometric Maneuvers in Patients with Type 1 Diabetes: A Case-Control Study.

Sanchez E, Mizab C, Sauret A, Barbe F, Marti R, Lopez-Cano C J Clin Med. 2020; 9(5).

PMID: 32344939 PMC: 7287574. DOI: 10.3390/jcm9051249.